3‐Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi‐Target‐Directed Ligands against Alzheimer's Disease-Reference-Cited by-同舟云学术

3‐Aryl Coumarin Derivatives Bearing Aminoalkoxy Moiety as Multi‐Target‐Directed Ligands against Alzheimer's Disease

Published:2019-04-08 Issue:5 Volume:16 Page:e1800436
ISSN:1612-1872
Container-title:Chemistry & Biodiversity
language:en
Short-container-title:C&B

Author:

Abdshahzadeh Helia¹,Golshani Mostafa²,Nadri Hamid³,Saberi Kia Iraj²,Abdolahi Zahra³,Forootanfar Hamid⁴,Ameri Alieh⁵,Tüylü Küçükkılınç Tuba⁶,Ayazgok Beyza⁶,Jalili‐Baleh Leili²,Sadat Ebrahimi Seyed Esmaeil¹,Moghimi Setareh²,Haririan Ismaeil⁷⁸,Khoobi Mehdi²⁹,Foroumadi Alireza¹¹⁰^ORCID

Affiliation:

1. Department of Medicinal Chemistry, Faculty of PharmacyTehran University of Medical Sciences Tehran 14176 Iran

2. The Institute of Pharmaceutical Sciences (TIPS)Tehran University of Medical Sciences Tehran 14176 Iran

3. Faculty of Pharmacy and Pharmaceutical Sciences Research CenterShahid Sadoughi University of Medical Sciences Yazd 37240171-035 Iran

4. Pharmaceutics Research Center, Institute of Neuropharmacology, KermanUniversity of Medical Sciences Kerman 7616913555 Iran

5. Department of Medicinal Chemistry, Faculty of PharmacyKerman University of Medical Sciences Kerman 7616913555 Iran

6. Hacettepe UniversityFaculty of Pharmacy, Department of Biochemistry 06100 Ankara Turkey

7. Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences InstituteTehran University of Medical Sciences Tehran 1416753955 Iran

8. Center of Excellence in Electrochemistry, Faculty of ChemistryUniversity of Tehran Tehran Iran

9. Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of PharmacyTehran University of Medical Sciences Tehran 1416753955 Iran

10. Neuroscience Research Center, Institute of NeuropharmacologyKerman University of Medical Sciences Kerman 7616913555 Iran

Publisher

Wiley

Subject

Molecular Biology,Molecular Medicine,General Chemistry,Biochemistry,General Medicine,Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbdv.201800436

Reference30 articles.

1. E. Scarpini P. Scheltens H. Feldman ‘Treatment of Alzheimer's disease: current status and new perspectives’ Lancet Neurol.2003 2 539–547.

2. M. Prince A. Wimo M. Guerchet G. C. Ali Y. T. Wu M. Prina ‘Alzheimer's Disease International’ King's College London UK 2015.

3. Z. Wang Y. Wang W. Li F. Mao Y. Sun L. Huang X. Li ‘Design Synthesis and Evaluation of Multitarget-Directed Selenium-Containing Clioquinol Derivatives for the Treatment of Alzheimer's Disease’ ACS Chem. Neurosci.2014 5 952–962.

4. M. G. Savelieff S. Lee Y. Liu M. H. Lim ‘Untangling amyloid-β tau and metals in Alzheimer's disease’ ACS Chem. Biol.2013 8 856–865.

5. S. S. Choi S.-R. Lee S. U. Kim H. J. Lee ‘Alzheimer's Disease and Stem Cell Therapy’ Exp. Neurol.2014 23 45–52.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of butyrylcholinesterase‐based biosensor for simultaneous determination of different toxicants using inhibition and reactivation steps;Electroanalysis;2024-02-21

2. Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive Impairment;ACS Chemical Neuroscience;2023-12-04

3. Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and β-Secretase for treatment of Alzheimer's disease;Journal of Molecular Structure;2022-08

4. Novel Coumarin–Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer’s Disease;Frontiers in Chemistry;2022-06-30

5. Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-04-19